APLS vs LYB · rev $781.4M vs P/E 21, rev $16.37B
Apellis Pharmaceuticals Inc (APLS) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Apellis Pharmaceuticals Inc (APLS) is a biotechnology company listed on US.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported APLS revenue for 2024-12-31 was $781.4M. Net income was -$197.9M. Revenue was up 97.0% from 2023-12-31 to 2024-12-31. APLS currently screens at market cap $2.29B.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
APLS currently screens at market cap $2.29B. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the APLS and LYB stock pages for the full models.
Not investment advice.